Black checkmark with a sparkle and a curved line underneath on a white background.
Company

HARTE HANKS INC

Ticker
HHS
Sector
Industry
Report date
August 15, 2026
Valye AI Score

71

High visibility
Recent developments
Recent developments summary

Recent developments include the announcement of a pending acquisition by Star Equity, quarterly earnings reports highlighting revenue declines and pension costs, and insider buying activity.

Recent developments:
  • Harte Hanks announced it will be acquired by Star Equity for $38.4 million, subject to customary closing conditions and regulatory approvals [N1].
  • The company reported Q3 2024 earnings amid pension-related costs, indicating ongoing operational expenses impacting profitability [N2].
  • Q2 2025 revenue declined by 14%, reflecting challenges in maintaining sales levels [N3].
  • Insider buying activity was reported in December 2024, suggesting some insider confidence in the company [N5].
  • An earnings preview in March 2025 highlighted recent insider trading and hedge fund activity, providing insight into investor sentiment [N4].
Overview

Harte Hanks Inc. operates as a publicly traded company with recent financial disclosures showing quarterly revenue and net loss figures. The company is engaged in a pending acquisition by Star Equity, which introduces operational restrictions and merger-related risks. Recent financial results indicate challenges including revenue declines and pension-related costs. The company faces uncertainties related to the completion and integration of the merger, as well as ongoing transaction expenses.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Harte Hanks Inc. reported $37.984 million in revenue and a net loss of $5.003 million for Q2 2026, with liquidity ratios indicating moderate short-term financial health. The company is currently subject to a pending acquisition by Star Equity valued at $38.4 million, with associated risks and transaction costs disclosed in recent SEC filings [S2].

Scenarios for HHS

Bull case model:

The pending acquisition by Star Equity could provide strategic benefits through combined operations and cost savings if successfully completed and integrated. The company's liquidity position, with a current ratio above 1, supports its ability to manage short-term obligations during this transition. Insider buying activity and ongoing business operations indicate some level of confidence in the company's prospects.

Bear case model:

The company reported a net loss and declining revenue in recent quarters, highlighting operational challenges. The merger is subject to multiple conditions and risks, including potential failure to complete, which could result in significant costs and management distraction. Restrictions on business activities prior to merger completion may limit operational flexibility. Integration risks post-merger could affect realization of anticipated benefits.

Moat:

The company's moat is not explicitly detailed in the available data. However, the pending acquisition by Star Equity and the associated strategic considerations suggest that Harte Hanks operates in a competitive environment where consolidation and cost synergies are relevant factors. The company's ability to maintain business relationships and manage operational restrictions during the merger process may influence its competitive positioning.

Risks overview
Risks summary
The primary risk is the uncertainty surrounding the completion and successful integration of the pending acquisition by Star Equity, which could materially affect the company's business and financial condition.
Risks details:

• Merger Completion Risk: The acquisition by Star Equity is subject to conditions that may not be satisfied, including stockholder approval and regulatory clearance, creating uncertainty about completion [S2].
• Operational Restrictions: Pre-merger restrictions limit the company's ability to modify contracts, hire or terminate employees, incur indebtedness, and make capital expenditures, potentially impacting business execution [S2].
• Transaction Costs: Significant non-recurring fees and costs related to the merger have been and will continue to be incurred, affecting financial results regardless of merger completion [S2].
• Integration Risk: Post-merger integration success depends on Star Equity's ability to realize anticipated benefits and cost savings, with no assurance of successful outcomes [S2].
• Business Uncertainty: Pending merger status may cause delays or changes in business relationships and employee retention challenges, impacting revenues and operations [S2].

FINAL FORECAST FOR HHS

Final take one line
Harte Hanks faces significant business and financial uncertainties amid a pending acquisition by Star Equity, with operational challenges and merger-related risks shaping near-term visibility.
Final take 12 to 24 month view

Business trends: Revenue declines and pension costs have pressured recent financial results; merger announcement signals strategic transition.
Execution milestones: Completion of the Star Equity acquisition, regulatory approvals, and successful integration are key milestones.
Key risks: Uncertainty of merger completion, operational restrictions pre-merger, transaction costs, and integration challenges pose material risks.

Valye AI Visibility Research Score

High visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

71
LLM visibility overview
LLM Visibility known facts
  • Harte Hanks Inc. is a publicly traded company with ticker HHS.
  • As of June 30, 2026, the company reported cash and cash equivalents of $5.185 million and current assets of $45.356 million against current liabilities of $34.871 million, resulting in a current ratio of 1.3 and a cash ratio of 0.15, indicating moderate liquidity.
  • For the quarter ended June 30, 2026, Harte Hanks reported revenue of $37.984 million and a net loss of $5.003 million, with basic and diluted EPS of -$0.67 per share.
  • The company is subject to a pending acquisition by Star Equity for $38.4 million, as announced in August 2026.
  • The merger is subject to several conditions including stockholder approval, regulatory clearance, and registration statement effectiveness, with risks that the transaction may not complete or may be delayed.
  • Pending merger-related restrictions affect the company's ability to conduct certain business activities, including contract modifications, asset transactions, hiring and compensation decisions, and incurring indebtedness.
  • The company has incurred and expects to continue incurring significant transaction fees and costs related to the merger, which may impact financial results.
  • Recent quarterly results showed a 14% decline in revenue in Q2 2025 compared to prior periods.
  • The company has disclosed risks related to the merger including potential adverse effects if the merger is not completed, such as costs incurred, management distraction, and impact on stock price.
  • The integration success post-merger depends on Star Equity's ability to realize anticipated benefits and cost savings, with no assurance of successful realization.
  • Recent news includes Q3 2024 earnings reporting amid pension costs and insider buying activity reported in December 2024.
Sources
Sources - Context summary

Generated 2026-08-15

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-17 | 10-K
  • S2 | 2026-08-14 | 10-Q
Sources - News headlines
  • N1 | 2026-08-14 | www.nasdaq.com | Harte Hanks To Be Acquired By Star Equity For $38.4 Mln | https://www.nasdaq.com/articles/harte-hanks-be-acquired-star-equity-384-mln
  • N2 | 2026-03-17 | www.nasdaq.com | Harte-Hanks, Inc. Reports Q3 2024 Earnings Amid Pension Costs | https://www.nasdaq.com/articles/harte-hanks-inc-reports-q3-2024-earnings-amid-pension-costs
  • N3 | 2025-08-08 | www.nasdaq.com | Harte Hanks (HHS) Q2 Revenue Falls 14% | https://www.nasdaq.com/articles/harte-hanks-hhs-q2-revenue-falls-14
  • N4 | 2025-03-11 | www.nasdaq.com | HARTE HANKS Earnings Preview: Recent $HHS Insider Trading, Hedge Fund Activity, and More | https://www.nasdaq.com/articles/harte-hanks-earnings-preview-recent-hhs-insider-trading-hedge-fund-activity-and-more
  • N5 | 2024-12-06 | www.nasdaq.com | Friday 12/6 Insider Buying Report: DMLP, HHS | https://www.nasdaq.com/articles/friday-12-6-insider-buying-report-dmlp-hhs
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine